Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder vote results from PepGen's 2026 Annual Meeting held on June 18, 2026. The filing reports voting outcomes for two proposals: election of three Class I directors (Mayer, Resnick, and Wyman) and ratification of KPMG LLP as independent auditor, with detailed vote tallies for each. This is a textbook Item 5.07 disclosure and is material to investors as it reflects stockholder approval of board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This 8-K Item 5.07 discloses the final voting results from American Well's 2026 annual stockholder meeting held on June 16, 2026, covering three proposals: election of directors (Dr. Ido Schoenberg), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory vote on named executive officer compensation. The filing presents the vote tallies (For, Withheld, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder voting results from Equity Residential's June 18, 2026 Annual Meeting of Shareholders under Item 5.07. The filing reports final voting tallies for three proposals: election of ten trustees, ratification of Ernst & Young LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with substantial majorities, making this a routine but material governance disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
CytomX held its Annual Meeting on June 17, 2026, with stockholders voting on seven proposals including election of Class II directors (Matthew P. Young and Elaine V. Jones Ph.D.), ratification of Ernst & Young LLP as auditor, authorization of additional common shares, amendments to the 2015 Equity Incentive Plan and Employee Stock Purchase Plan, advisory approval of named executive officer compensation, and the frequency of future advisory compensation votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the final voting results from Atea Pharmaceuticals' June 18, 2026 Annual Meeting of Stockholders, including the election of three Class III directors (Jerome Adams, Howard Berman, and Barbara Duncan), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents certified vote tallies for each proposal and confirms their passage, which is the core purpose of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
Eledon Pharmaceuticals held its Annual Meeting of Stockholders on June 22, 2026, at which shareholders voted on and approved three proposals: election of Class III Directors (Gros, Hillson, Robinson), approval of an amendment to increase authorized common shares from 300 million to 450 million, and ratification of Deloitte & Touche LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
nCino held its Annual Meeting of Stockholders on June 18, 2026, with shareholders voting on and approving four proposals: election of directors (Jon Doyle, William Spruill, Diego Dugatkin, and Andy Yasutake), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and approval of a charter amendment permitting stockholder removal of directors with or without cause.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder vote results from the Annual Meeting of Stockholders held on June 22, 2026. The filing presents tabulated voting results for two proposals: (1) election of eight directors and (2) ratification of BDO USA, P.C. as independent auditor. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose explicitly states vote counts for each director and proposal, making this a material governance event affecting investor understanding of board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
This Item 5.07 discloses the final results of a Special Meeting of Stockholders held on June 18, 2026, where stockholders voted on two proposals to approve issuances of common stock pursuant to Nasdaq Rule 5635 — specifically approving up to 925,927 shares from Series A and B Warrants (Proposal 1) and 2,344,828 shares from Common Warrants (Proposal 2). Both proposals passed with overwhelming majorities. The disclosure of shareholder vote results at a stockholder meeting is the core purpose of Item 5.07, and approval of dilutive warrant exercises is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the final results of Unicycive's Annual Meeting of Stockholders held on June 19, 2025, including the election of three directors (Dr. Shalabh Gupta, Dr. Sandeep Laumas, and D. Sarawati Kenkare-Mitra) and ratification of Grassi & Co. CPAs as the independent auditor. The filing explicitly presents vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-22
EX-99.1
The press release announces the results of an extraordinary general meeting of shareholders held on June 19, 2026, where shareholders voted to approve a merger agreement between LakeShore Biopharma, Oceanpine Skyline Inc., and Oceanpine Merger Sub Inc. Approximately 92.3% of outstanding shares voted, with 86.2% of votes cast approving the merger. This is a shareholder vote result on a material transaction (merger) that will result in the company becoming privately held and delisted from public markets.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder vote results under Item 5.07. The filing reports the outcome of a special meeting held on June 18, 2026, where stockholders voted on a reverse stock split proposal with specific voting tallies: 42,878,771 votes for, 2,210,259 against, and 22,102 abstentions. The reverse stock split authorization is material to investors as it affects share structure and potential delisting risk mitigation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
Shareholders voted at the 2026 Annual Meeting held on June 15, 2026, approving the election of five directors (Alexandre Weinstein, Eitan Ajchenbaum, Rami Levi, Maital Shemesh-Rasmussen, and Yaky Yanay) and ratifying Kesselman & Kesselman as the independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the results of Penumbra's Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on three proposals: election of Class II directors (Arani Bose, Bridget O'Rourke, and Surbhi Sarna), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies and broker non-votes are characteristic of shareholder vote result disclosures required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This 8-K Item 5.07 discloses the certified results of Expedia's 2026 Annual Meeting of Stockholders held on June 17, 2026, including voting outcomes on three proposals: election of 11 directors, advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies for each director nominee and proposal are the core disclosure, which is the defining characteristic of shareholder_vote_results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder vote results from Workday's Annual Meeting of Stockholders held on June 16, 2026. The filing reports certified voting outcomes on seven proposals, including director elections, auditor ratification, executive compensation approval, equity plan amendments, and stockholder proposals. The high quorum (97.58% of eligible votes) and detailed vote tallies for each matter are characteristic of Item 5.07 disclosures, which are material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder voting results from HireQuest's 2026 Annual Meeting of Stockholders held on June 18, 2026. The filing reports final voting tallies for three proposals: election of six directors, ratification of Forvis Mazars as independent auditor, and a non-binding advisory vote on named executive officer compensation. This is a quintessential Item 5.07 disclosure and material to investors as it reflects stockholder approval of governance and oversight matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
At Capstone Holding Corp.'s June 18, 2026 annual meeting, shareholders approved six proposals with substantial majorities: election of Class I and Class II directors, ratification of GBQ Partners LLC as auditors, approval of a reverse stock split (1-for-5 to 1-for-50 ratio), amendment to the 2025 Stock Incentive Plan to increase share availability from 21.5% to 35%, and adjournment of the meeting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 filing discloses the results of Sypris Solutions' Annual Meeting of Stockholders held on June 16, 2026, including voting outcomes for the election of Class III directors (William G. Ferko and Jeffrey T. Gill) and an advisory vote on named executive officer compensation. The disclosure presents vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, and BROKER NON-VOTES) for each proposal, which is the standard format for shareholder vote results required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
This Item 5.07 filing discloses the results of the 2026 Annual Meeting of shareholders held on June 18, 2025, including voting outcomes on three matters: election of Class I directors (Dr. Satis Waran Nair Krishnan and Inigo Angel Laurduraj, each receiving ~69% of votes cast), ratification of SFAI Malaysia Plt. as independent auditors (78.3% approval), and advisory approval of executive compensation (68.9% approval). The filing presents tabulated voting results with vote counts and percentages for each proposal, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
The filing discloses Item 5.07 results from Harrow's 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes for director elections (all four nominees elected), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. This is a standard shareholder vote results disclosure that materially informs investors of governance decisions and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
The filing discloses Item 5.07 results from Dyadic International's June 18, 2026 Annual Meeting of Shareholders, including voting outcomes on four proposals: election of a Class I director (Seth J. Herbst, M.D.), authorization for a reverse stock split, ratification of Crowe LLP as independent auditor, and an advisory vote on named executive officer compensation. These are standard shareholder vote results that materially inform investors about governance and capital structure decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
The filing discloses results of an annual meeting of stockholders held on June 18, 2026, with tabulated voting results for five proposals: election of four directors, advisory vote on executive compensation, ratification of auditor selection, authorization for a reverse stock split (1-for-10 to 1-for-50), and authorization to decrease authorized shares. This is a classic Item 5.07 shareholder vote results disclosure, and the reverse stock split authorization is material to investors as it affects share structure and capital allocation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
The filing discloses results of a special stockholder meeting held on June 18, 2026, where shareholders voted on and approved a reverse stock split proposal (1-for-2 to 1-for-20 ratio). Item 5.07 explicitly reports the voting results: 5,177,506 votes for, 1,222,793 against, 87,461 abstain. The Board subsequently approved a 1-for-20 reverse split ratio to achieve compliance with Nasdaq's $1.00 minimum bid price rule by July 31, 2026. This is a material governance event affecting share structure and listing compliance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-06-22
The filing's primary disclosure is Item 5.07 (Submission of Matters to a Vote of Security Holders), reporting results from GameSquare's June 18, 2026 Annual Meeting. While the filing also covers a merger with a wholly owned subsidiary (Item 1.01) and certificate amendments (Item 5.03), the merger is a technical recapitalization that does not involve a third party or change of control—it is a vehicle for restating the certificate of incorporation. The substantive event is stockholder approval of four proposals, including the merger agreement, director elections, auditor ratification, and say-on-pay, with detailed voting tallies provided. This is a material shareholder vote disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
The filing discloses Item 5.07 results from Sidus Space's Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on four proposals: election of six directors, ratification of auditors (Fruci & Associates, PLLC), approval of equity plan share increase (800,000 to 4,800,000 shares), and rejection of an evergreen provision amendment. These are standard shareholder vote results that materially affect governance and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
The filing discloses results of a Special Meeting of Stockholders held on June 16, 2026, where shareholders voted on and approved three warrant-related proposals: authorization of warrant share issuance (including shares exceeding 19.99% of outstanding common stock), adjustment of shares issuable upon warrant exercise, and adjustment of warrant exercise prices. The vote tallies are provided for each proposal, directly matching Item 5.07 disclosure requirements for shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
The filing discloses results of the Company's 2026 Annual Meeting of Stockholders held on June 16, 2026, under Item 5.07. The disclosure reports voting outcomes for two proposals: (1) election of John Smither as Class I Director with 8,696,891 votes for and 3,393,408 withheld, and (2) ratification of Weinberg & Company, P.A. as independent auditor with 28,092,768 votes for. These are standard shareholder vote results that materially inform investors of governance decisions and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-06-22
The filing's primary disclosure is Item 5.07, which reports the results of MARA Holdings' June 18, 2026 annual stockholder meeting. The filing details voting outcomes for four proposals: election of Class III directors (Vicki Mealer-Burke and Douglas Mellinger), ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2018 Equity Incentive Plan increasing authorized shares by 18 million. While Item 5.02 references the equity plan amendment, the substantive disclosure centers on shareholder voting results, making this a shareholder_vote_results event material to investors assessing governance and capital structure decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
The filing discloses results of SurgePays' annual meeting of stockholders held on June 16, 2026, under Item 5.07. The company reports voting results for three proposals: election of four directors (Kevin Brian Cox, David N. Keys, David May, and Laurie Weisberg), ratification of TAAD, LLP as independent auditor, and approval of securities purchase agreements with institutional investors involving issuance of 20%+ of common stock. All proposals were approved by requisite stockholder vote, making this a standard shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
This Item 5.07 filing discloses the results of Akebia's 2026 Annual Meeting of Stockholders held on June 17, 2026, including five proposals: election of three Class III directors (Adrian Adams, Michael Rogers, LeAnne M. Zumwalt), approval of a Share Increase Amendment increasing authorized shares from 375M to 525M, non-binding advisory vote on named executive officer compensation, frequency recommendation for future compensation votes, and ratification of Ernst & Young LLP as independent auditor. The disclosure of shareholder vote results is the core event, and the outcomes—particularly the significant share authorization increase and director elections—are material to investors' understanding of the company's capital structure and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder voting results from PagerDuty's June 18, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports final voting tallies for three proposals: election of four Class I directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material governance disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder voting results from the Company's 2026 Annual Meeting of Stockholders held on June 17, 2026. The filing presents detailed voting tallies for three proposals: election of nine directors, ratification of KPMG LLP as independent auditor, and an advisory vote on executive compensation. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
OneMain Holdings held its 2026 Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on five proposals: election of two Class I directors (Caldwell and Guthrie), advisory approval of named executive officer compensation, annual frequency for future say-on-pay votes, approval of the 2026 Omnibus Incentive Plan, and ratification of PricewaterhouseCoopers LLP as independent auditor. All proposals were approved with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder voting results from GrowGeneration's 2026 Annual Meeting held on June 18, 2026, covering four proposals: election of five directors, say-on-pay advisory vote, equity plan amendment, and independent auditor appointment. Item 5.07 explicitly requires disclosure of shareholder vote results, and the filing presents detailed voting tallies for each proposal, making this a textbook shareholder_vote_results event that is material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
Allogene held its 2026 Annual Meeting of Stockholders on June 18, 2026, with final voting results reported for five proposals: election of three Class II directors (Messemer, Sato, Witte), advisory approval of named executive officer compensation, say-on-pay frequency (approved annually), amendment to increase authorized shares from 400 million to 800 million, and ratification of Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder voting results from OPAL Fuels' 2026 Annual Meeting of Stockholders held on June 17, 2026. The filing presents detailed voting tallies for two proposals: election of eight directors and ratification of BDO USA, P.C. as independent auditor. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly reports the FOR/WITHHELD/AGAINST votes cast on each matter.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder voting results from National Vision's June 17, 2026 annual meeting of stockholders. The filing presents the outcomes of three proposals: election of eleven directors, advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as independent auditor. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly reports vote tallies (For, Against, Abstain, Broker Non-Vote) for each proposal, which is the standard format for this event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of GRAIL's Annual Meeting of Stockholders held on June 18, 2026. The filing presents voting results for two proposals: election of two Class II Directors (Sarah Krevans and Steven Mizell) and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (votes for, withheld, broker non-votes, and abstentions) are the core content of the disclosure, making this unambiguously a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the results of an annual stockholder meeting held on June 17, 2026, where shareholders voted on two proposals: (1) election of Phil Garfinkle as a Class II director and (2) ratification of Baker Tilly US, LLP as independent accountants for fiscal year 2026. Both votes are routine governance matters with clear voting tallies, making this a straightforward shareholder_vote_results classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear disclosure of shareholder vote results from Cronos Group's 2026 Annual Meeting of Shareholders held on June 18, 2026, covering four proposals: election of seven directors, advisory approval of named executive officer compensation, frequency of say-on-pay votes, and appointment of the independent auditor. The filing presents final voting tallies for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This 8-K Item 5.07 discloses the final voting results from Crinetics Pharmaceuticals' annual stockholder meeting held June 18, 2026, covering three proposals: election of three Class II directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents complete vote tallies (For, Against/Withheld, Abstentions, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the results of Inseego Corp.'s June 16, 2026 annual stockholder meeting, including voting outcomes for three proposals: election of two directors (James B. Avery and Jeffrey Tuder), ratification of CBIZ CPAs P.C. as independent auditors, and an advisory vote on executive compensation. The filing presents vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Delta Air Lines' 2026 Annual Meeting of Shareholders held on June 18, 2026. The filing presents voting results for five proposals: election of fourteen directors, advisory vote on executive compensation, ratification of Ernst & Young LLP as independent auditors, and two shareholder proposals (written consent and cumulative voting). The detailed vote tallies for each matter are the core content of the disclosure, making this unambiguously a shareholder vote results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-22
Item 5.07
The majority stockholder (Hawkeye Holdco, LLC, holding 90.1% of voting power) approved by written consent multiple fundamental corporate actions: a name change to Hawkeye Digital, Inc., an increase in authorized shares from 450 million to 10.05 billion, a reclassification of the Board into three classes, authorization for a reverse stock split (1-for-2 to 1-for-20), and adoption of an Equity Incentive Plan. These structural changes materially affect the company's capital structure and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 disclosure reports the results of Butterfly Network's 2026 Annual Meeting of Stockholders held on June 18, 2026, with detailed voting tallies for three proposals: (1) election of seven directors, (2) ratification of Deloitte & Touche LLP as independent auditor, and (3) advisory vote on named executive officer compensation. The filing explicitly states the vote counts for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from the Company's June 18, 2026 annual meeting of stockholders. The filing reports voting outcomes on three proposals: election of two Class II directors (Neil Glat and Richard Shapiro), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All proposals passed. This is material as it reflects shareholder governance decisions and auditor ratification.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-22
EX-99.2
SOPHiA GENETICS held its 2026 Annual General Meeting of shareholders, approving all proposals including the election of Dr. Jurgi Camblong as Executive Chairman (99.79% approval) and Ross Muken as a new Board member and incoming CEO effective July 1, 2026 (99.88% approval), reflecting a significant leadership transition and governance restructuring.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-22
Item 5.07
This Item 5.07 filing discloses the results of Blend Labs' June 17, 2026 annual meeting of stockholders, including voting outcomes for the election of seven directors and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents tabulated vote counts (For, Against, Withheld, Broker Non-Votes) for each proposal, confirming all director nominees were elected and the auditor appointment was ratified. This is a classic shareholder_vote_results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder voting results from the June 16, 2026 Annual Meeting of Shareholders under Item 5.07. The filing reports detailed vote tallies for four proposals: election of 7 directors, ratification of Grant Thornton LLP as auditor, Say-On-Pay advisory vote, and approval of the amended Omnibus Incentive Plan. All proposals passed with strong majorities, making this a material disclosure of shareholder actions that affects the composition of the board and governance structure.
View raw filing on EDGAR →